Search





Search





Markets
/
Stocks
/
nasdaq-nams
/

NewAmsterdam Pharma Company NV

NAMS

Add to Watchlist

35.440USD

-1.440-3.90%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

4.13BMarket Cap

LossP/E TTM



NewAmsterdam Pharma Company NV

35.440

-1.440-3.90%

Overview Financials Discussions Analysis Company

Overview

Financials

Discussions

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of NewAmsterdam Pharma Company NV to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q3

FY2023Q2

FY2023Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

16.08%-30.60M

-9.06%-40.88M

-162.11%-32.77M

30.21%-37.67M

33.21%-36.47M

---37.48M

73.39%-12.50M

-84.20%-53.98M

-71.36%-54.60M

---46.98M

---29.30M

---31.86M

Net income from continuing operations

-22.55%-48.44M

18.72%-74.92M

-332.54%-72.00M

55.48%-17.36M

57.85%-39.53M

---92.18M

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

---47.13M

---38.29M

---42.02M

Operating gains losses

19.23%62.00K

15.69%59.00K

128.57%64.00K

136.84%45.00K

246.67%52.00K

--51.00K

100.00%28.00K

46.15%19.00K

66.67%15.00K

--14.00K

--13.00K

--9.00K

Other non-cash items

133.46%1.61M

-99.28%55.00K

86.87%-614.00K

-1013.45%-9.10M

-298.55%-4.80M

--7.64M

-248.15%-4.68M

1264.38%996.00K

178.92%2.42M

--3.16M

--73.00K

---3.06M

Change in working capital

-60.43%4.10M

157.21%4.57M

3410.71%983.00K

-63.48%-23.84M

202.11%10.35M

---7.98M

100.48%28.00K

-587.47%-14.59M

-1647.76%-10.14M

---5.88M

--2.99M

---580.00K

-Change in prepaid expenses

-5.07%15.22M

-15.81%-10.06M

630.22%2.61M

-136.80%-21.86M

1576.88%16.03M

---8.69M

83.84%-493.00K

-269.36%-9.23M

167.66%956.00K

---3.05M

--5.45M

---1.41M

-Change in other current liabilities

100.00%0.00

163.52%3.99M

100.00%0.00

-32.95%-3.03M

-112.56%-2.98M

--1.51M

39.29%-1.79M

-32.73%-2.28M

56.81%-1.40M

---2.94M

---1.72M

---3.24M

Cash from non-recurring investing activities

Cash from operating activities

16.08%-30.60M

-9.06%-40.88M

-162.11%-32.77M

30.21%-37.67M

33.21%-36.47M

---37.48M

73.39%-12.50M

-84.20%-53.98M

-71.36%-54.60M

---46.98M

---29.30M

---31.86M

Investing cash flow

Net cash from continuing investing activities

137.50%38.00K

3233.33%100.00K

-44.00%42.00K

-57.89%88.00K

-95.84%16.00K

--3.00K

733.33%75.00K

4080.00%209.00K

5400.00%385.00K

--9.00K

--5.00K

--7.00K

Capital expenditures

137.50%38.00K

3233.33%100.00K

-44.00%42.00K

-57.89%88.00K

-95.84%16.00K

--3.00K

733.33%75.00K

4080.00%209.00K

5400.00%385.00K

--9.00K

--5.00K

--7.00K

Net cash flow from disposal of fixed assets

137.50%38.00K

3233.33%100.00K

-44.00%42.00K

-57.89%88.00K

-95.84%16.00K

--3.00K

733.33%75.00K

4080.00%209.00K

5400.00%385.00K

--9.00K

--5.00K

--7.00K

Net cash flow from investment products

-499.55%-11.47M

66.16%-21.04M

--2.55M

---159.05M

--2.87M

---62.18M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-503.12%-11.51M

66.00%-21.14M

3441.33%2.51M

-76041.63%-159.14M

841.56%2.85M

---62.18M

-733.33%-75.00K

-4080.00%-209.00K

-5400.00%-385.00K

---9.00K

---5.00K

---7.00K

Financing cash flow

Cash flow from continuous financing activities

69.73%11.06M

-97.00%13.68M

10058.62%5.89M

-26.47%3.42M

-96.71%6.52M

--456.61M

-68.82%58.00K

-26.46%4.66M

8185.12%198.18M

--186.00K

--6.33M

--2.39M

Net cash flow from common stock issuance/repurchase

----

--0.00

----

--455.03M

--0.00

--190.48M

----

--0.00

Proceeds from stock option exercised by employees

31.46%10.41M

884.57%12.50M

9586.21%5.62M

--3.42M

1700.45%7.92M

--1.27M

-68.65%58.00K

-100.00%0.00

--440.00K

--185.00K

--105.00K

--0.00

Proceeds from issuance of warrants

255.74%651.00K

247.06%1.18M

--274.00K

-99.98%1.00K

-97.91%183.00K

--340.00K

-100.00%0.00

-25.22%4.66M

266.35%8.76M

--1.00K

--6.23M

--2.39M

Net cash flow from other financing activities

100.00%0.00

--0.00

-5.45%-1.59M

---25.00K

--0.00

---1.50M

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

69.73%11.06M

-97.00%13.68M

10058.62%5.89M

-26.47%3.42M

-96.71%6.52M

--456.61M

-68.82%58.00K

-26.46%4.66M

8185.12%198.18M

--186.00K

--6.33M

--2.39M

Net cash flow

Beginning cash balance

-36.34%491.32M

27.67%539.72M

30.92%563.86M

55.55%748.42M

126.68%771.74M

--422.73M

3.36%430.71M

9.03%481.15M

-27.21%340.45M

--416.71M

--441.31M

--467.73M

Current period cash flow changes

-38.83%-32.38M

-113.87%-48.39M

-202.66%-24.15M

-265.90%-184.56M

-116.58%-23.32M

--349.01M

83.51%-7.98M

-104.99%-50.44M

632.62%140.70M

---48.40M

---24.61M

---26.42M

Effect of exchange rate changes

-135.32%-1.33M

99.24%-60.00K

-95.11%222.00K

1070.96%8.83M

251.08%3.77M

---7.94M

383.75%4.54M

44.23%-909.00K

-181.52%-2.50M

---1.60M

---1.63M

--3.06M

Ending cash balance

-38.68%458.94M

-36.34%491.32M

27.67%539.72M

30.92%563.86M

55.55%748.42M

--771.74M

14.78%422.73M

3.36%430.71M

9.03%481.15M

--368.31M

--416.71M

--441.31M

Free cash flow

16.01%-30.64M

-9.31%-40.98M

-160.88%-32.81M

30.32%-37.76M

33.65%-36.48M

---37.48M

73.23%-12.58M

-84.88%-54.19M

-72.54%-54.99M

---46.98M

---29.31M

---31.87M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

